5T5-38011-51617
3 vaccinations
1 coded response
13 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 531 / WI
- Registered
- 2021-02-25
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-04
Dose 1 — Pfizer-BioNTech
-
2021-02-25
Registered in v-safe
-
2021-02-25
Dose 2 — Pfizer-BioNTech
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-02
- 2021-08-26
-
2021-10-11
Dose 3 — Pfizer-BioNTech
- 2021-10-11
-
2021-10-12
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
- 2021-10-13
- 2021-10-21
- 2021-10-25
- 2021-11-11
-
2021-11-22
Survey response — day 42, dose 3MedDRA: Visual impairment — Feeling: FairFree text: Vision affected.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-04 | Pfizer-BioNTech | |
| 2 | 2021-02-25 | Pfizer-BioNTech | |
| 3 | 2021-10-11 | Pfizer-BioNTech | No |
Free text
Release 10 — day 42, dose 3
Symptoms: Vision affected.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Visual impairment | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release